среда, 30 марта 2016 г.

Analysts' Recent Ratings Changes for Meridian Bioscience

Analysts' Recent Ratings Changes for Meridian Bioscience


They now have a $20.00 price target on the stock. 3/28/2016 - Meridian Bioscience had its price target raised by analysts at Canaccord Genuity from $18.00 to $19.00.



from Biotech News